Balchem Corp (BCPC)
Balchem makes specialty ingredients and performance gases for nutrition, food, animal health, agriculture and industrial customers. It last closed at $169.63 on Nov 17, down 1.08% on the day. BCPC last reported earnings on Fri, Oct 23, 2026.
Key Stats
Last 12 monthsNot reported for this period.
From BCPC's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 23). Last 12 months adds up the four latest quarters.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 1 analyst who set a price target on BCPC in the past 90 days. The average target is $210.00, with a high of $210.00 and a low of $210.00, compared with the last close of $169.63.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 26 | HC Wainwright & Co. | Target lowered | Buy | $215 → $210 |
| Aug 3 | HC Wainwright & Co. | Maintained | Buy | $215 |
Technical Analysis
The stock is 2% below its 20 day and 0% below its 50 day average. It is sitting right on its 200 day average, a level many traders watch. Momentum is weak (RSI 45). The nearest support is the Pivot S1 at $168.66, and the nearest resistance the 200 day average at $169.66.
| RSI (14) | 45.06 | Middle of its range | Neutral |
| MACD | 0.51 | Below its signal line | Bearish |
| Stochastic | 26.7 | Middle of its range | Neutral |
| ADX (14) | 20.4 | Weak trend | |
| Williams %R | -84.2 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -82.4 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | −3.4% | Change over 10 sessions | Bearish |
| ATR (14) | $4.14 | Typical daily range, 2.4% of price |
| RSI (14) | 49.86 | Middle of its range | Neutral |
| MACD | 1.27 | Below its signal line | Bearish |
| Stochastic | 45.2 | Middle of its range | Neutral |
| ADX (14) | 11.0 | No clear trend | |
| Williams %R | -65.8 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | 1.3 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | +3.2% | Change over 10 sessions | Bullish |
| ATR (14) | $8.31 | Typical daily range, 4.9% of price |
What happened before
See how BCPC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How BCPC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
Whale Options Flow
90DNo whale options trades in BCPC in the last 90 days.
BCPC Institutional Ownership
Full report →- ▲220 buying vs 178 selling
- ▼Held by funds -1.5 pts
- ▲Funds holding +11
- ▲Superinvestors: 3 added, 2 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 430 | 419 | +2.6% |
| In funds' top 10 | 5 | 5 | 0.0% |
| Held by funds | 90.4% | 91.9% | −1.5 pts |
| New / increased | 55 / 165 | 46 / 141 | +17.6% |
| Reduced / sold out | 138 / 40 | 161 / 50 | −15.6% |
| Put/call ratio | – | – | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BCPC is in one of them and how their past BCPC trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered BCPC in an article yet. Here's the latest on the wider market.
BCPC Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Sep 17, 2026 | Oct 12, 2026 | 25 d |
| Donald J TrumpExecutive branch | Sell | $50K – $100K | Jul 29, 2026 | Sep 22, 2026 | 55 d |
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Jul 10, 2026 | Sep 4, 2026 | 56 d |
| Donald J TrumpExecutive branch | Sell | $15K – $50K | May 15, 2026 | Jul 1, 2026 | 47 d |
| Donald J TrumpExecutive branch | Other | $15K – $50K | Mar 30, 2026 | May 14, 2026 | 45 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Balchem
Balchem develops, makes and sells specialty ingredients for the nutritional, food, pharmaceutical, animal health, plant nutrition, sterilization and industrial markets. Its human nutrition products include choline, mineral chelates and vitamin K2 for supplement makers and food and beverage manufacturers. It also sells choline chloride and other animal feed ingredients, mainly to poultry, pet and swine producers, and distributes sterilant and fumigant gases to health care and food processing customers. The company is based in Montvale, New Jersey.
- Headquarters
- Montvale, NJ









